By Sneha S K and Puyaan Singh (Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's ...
Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co. Zepbound and generic ...
Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ...
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...
Medpage Today on MSN10h
Endocrine Society Condemns HHS Purge; Lilly Sues Compounders; Obesity Rising in T1DCombination treatment with a GLP-1 agonist and thiazolidinedione in type 2 diabetes was tied to a significantly lower risk of ...
19hon MSN
Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 ...
We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...
Hims & Hers Health (NYSE:HIMS) stock gains as the company adds Eli Lilly's (LLY) weight loss therapy tirzepatide & generic ...
Lilly continues full-court press against breast cancer with women's March Madness event sponsorships
As the women’s NCAA March Madness tournament draws to a close, Eli Lilly is aiming for a slam dunk of its own. | As the women ...
Eli Lilly ( NYSE: LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass ...
WVNS Bluefield on MSN5h
Avery Lilly signs with Concord, continuing her athletic career in cross country, track and fieldIn fall 2025, Summers County Comprehensive High School athlete Avery Lilly will be trading in her orange and black gear for some maroon and gray. She declared her commitment to Concord University to ...
Hims shares gained as much as 14% in New York, their biggest gain since Feb. 19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback